219 related articles for article (PubMed ID: 12727801)
1. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke.
Faraglia B; Chen SY; Gammon MD; Zhang Y; Teitelbaum SL; Neugut AI; Ahsan H; Garbowski GC; Hibshoosh H; Lin D; Kadlubar FF; Santella RM
Carcinogenesis; 2003 Apr; 24(4):719-25. PubMed ID: 12727801
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
3. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
4. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
[TBL] [Abstract][Full Text] [Related]
5. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
7. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer.
Martone T; Airoldi L; Magagnotti C; Coda R; Randone D; Malaveille C; Avanzi G; Merletti F; Hautefeuille A; Vineis P
Int J Cancer; 1998 Feb; 75(4):512-6. PubMed ID: 9466649
[TBL] [Abstract][Full Text] [Related]
8. Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass Spectrometry.
Guo J; Villalta PW; Weight CJ; Bonala R; Johnson F; Rosenquist TA; Turesky RJ
Chem Res Toxicol; 2018 Dec; 31(12):1382-1397. PubMed ID: 30387604
[TBL] [Abstract][Full Text] [Related]
9. DNA adducts of the tobacco carcinogens 2-amino-9H-pyrido[2,3-b]indole and 4-aminobiphenyl are formed at environmental exposure levels and persist in human hepatocytes.
Nauwelaërs G; Bellamri M; Fessard V; Turesky RJ; Langouët S
Chem Res Toxicol; 2013 Sep; 26(9):1367-77. PubMed ID: 23898916
[TBL] [Abstract][Full Text] [Related]
10. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
11. Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations.
Bendaly J; Doll MA; Millner LM; Metry KJ; Smith NB; Pierce WM; Hein DW
Mutat Res; 2009 Dec; 671(1-2):13-9. PubMed ID: 19682468
[TBL] [Abstract][Full Text] [Related]
12. Carotenoids/vitamin C and smoking-related bladder cancer.
Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
14. Bioactivation of the tobacco carcinogens 4-aminobiphenyl (4-ABP) and 2-amino-9H-pyrido[2,3-b]indole (AαC) in human bladder RT4 cells.
Bellamri M; Yao L; Bonala R; Johnson F; Von Weymarn LB; Turesky RJ
Arch Toxicol; 2019 Jul; 93(7):1893-1902. PubMed ID: 31203411
[TBL] [Abstract][Full Text] [Related]
15. 4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice.
Tsuneoka Y; Dalton TP; Miller ML; Clay CD; Shertzer HG; Talaska G; Medvedovic M; Nebert DW
J Natl Cancer Inst; 2003 Aug; 95(16):1227-37. PubMed ID: 12928348
[TBL] [Abstract][Full Text] [Related]
16. Aromatic amine DNA adduct formation in chronically-exposed mice: considerations for human comparison.
Poirier MC; Beland FA
Mutat Res; 1997 May; 376(1-2):177-84. PubMed ID: 9202754
[TBL] [Abstract][Full Text] [Related]
17. DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry.
Gu D; Turesky RJ; Tao Y; Langouët SA; Nauwelaërs GC; Yuan JM; Yee D; Yu MC
Carcinogenesis; 2012 Jan; 33(1):124-30. PubMed ID: 22072616
[TBL] [Abstract][Full Text] [Related]
18. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
19. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.
Chen SY; Wang LY; Lunn RM; Tsai WY; Lee PH; Lee CS; Ahsan H; Zhang YJ; Chen CJ; Santella RM
Int J Cancer; 2002 May; 99(1):14-21. PubMed ID: 11948486
[TBL] [Abstract][Full Text] [Related]
20. CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice.
Kimura S; Kawabe M; Ward JM; Morishima H; Kadlubar FF; Hammons GJ; Fernandez-Salguero P; Gonzalez FJ
Carcinogenesis; 1999 Sep; 20(9):1825-30. PubMed ID: 10469630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]